NDC11 84141002501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 84141-0025-01 | 84141-0025 |
| 84141-0025-1 | 84141-0025 |
| 84141-025-01 | 84141-025 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REDEMPLO | PLOZASIRAN | Arrowhead Pharmaceuticals, Inc. | 7fd37993-f85a-4af1-8bbe-133299f226ed | 2026-08-25 | Adverse reactions | 84141-025-01 84141-025 84141002501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.